Literature DB >> 3258321

Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study.

T Ogawa1, K Uemura, F Shishido, T Yamaguchi, M Murakami, A Inugami, I Kanno, H Sasaki, T Kato, K Hirata.   

Abstract

The effects of radiochemotherapy on blood flow, blood volume, and consumption of oxygen and glucose in tumor tissue and normal brain were studied by positron emission tomography. Thirteen patients with cerebral gliomas were included, and they were examined before, during, and within approximately 1 month after the therapy. The 15O-labeled gas steady state inhalation and the 18F-fluorodeoxyglucose methods were used. After the therapy, glucose consumption and blood volume decreased (p less than 0.03) in the tumoral tissue. In the structurally (CT) normal gray matter, blood flow, blood volume, and oxygen consumption did not show any significant changes; oxygen extraction fraction, glucose consumption, and glucose extraction fraction, however, decreased significantly (p less than 0.05, less than 0.02, and less than 0.03, respectively).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258321     DOI: 10.1097/00004728-198803000-00019

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  17 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

3.  Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.

Authors:  H Minn; R Paul
Journal:  Eur J Nucl Med       Date:  1992

4.  Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.

Authors:  M Würker; K Herholz; J Voges; U Pietrzyk; H Treuer; B Bauer; V Sturm; W D Heiss
Journal:  Eur J Nucl Med       Date:  1996-05

Review 5.  On the principles underlying the diagnosis of brain tumours--a survey article.

Authors:  K G Go; R L Kamman; J Pruim; J M Hew; W Vaalburg; A M Paans; E L Mooyaart; M A Heesters; F H Lopes da Silva
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.

Authors:  A G Vlassenko; B Thiessen; B J Beattie; M G Malkin; R G Blasberg
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

Review 7.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Experimental transplantation gliomas in the adult cat brain. 3. Regional biochemistry.

Authors:  F Linn; K Seo; K A Hossmann
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 9.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

10.  Peripheral benzodiazepine receptors and glucose metabolism in human gliomas.

Authors:  C Ferrarese; C Pierpaoli; I Linfante; R H Bobo; B Guthrie; C Kufta; M O Duhaney; J Melisi; M J Fulham
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.